HighTower Advisors »

Crispr Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 38k 62.88
2023-09-30 $1.8M 40k 45.31
2023-06-30 $2.2M 40k 56.21
2023-03-31 $1.8M 40k 45.26
2022-12-31 $1.2M 31k 40.34
2022-09-30 $2.3M 35k 65.52
2022-06-30 $2.1M 34k 60.64
2022-03-31 $3.1M 50k 62.73
2021-12-31 $2.5M 33k 76.16
2021-09-30 $4.8M 43k 111.91
2021-06-30 $6.5M 40k 161.71
2021-03-31 $3.6M 30k 121.52
2020-12-31 $4.1M 27k 153.11
2020-09-30 $2.1M 25k 83.57
2020-06-30 $1.9M 25k 73.39
2020-03-31 $873k 21k 42.48
2019-12-31 $1.1M 19k 60.59
2019-09-30 $722k 18k 40.96
2019-06-30 $1.1M 23k 47.11
2019-03-31 $721k 20k 35.79
2018-12-31 $480k 17k 28.76
2018-09-30 $1.1M 24k 44.21
2018-06-30 $1.1M 19k 58.79